Abstract
Endothelin (ET) receptors belong to the G-protein-linked seven transmembrane spanning family of receptors, located in the plasma membrane. Receptors can be identified by their amino acid structure and provide unambiguous evidence for expression of a gene encoding a particular sub-type in specific cells or tissues (see Chapter 6).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Arai H., Hori S., Aramori I., Ohkubo H., and Nakanishi S. (1990) Cloning and expression of a cDNA encoding an endothelin receptor. Nature 348, 730–732.
Sakurai T., Yanagisawa M., Takuwa Y., Miyazaki H., Kimura S., Goto K., and Masaki T. (1990) Cloning of a cDNA encoding a nonisopeptide-selective subtype of the endothelin receptor. Nature 348, 732–735.
Davenport A.P. (2000) Endothelin receptors. Iuphar Compendium of Receptor Characterisation and Classification, 2nd edition. Iuphar Media London, UK. 182–188.
Davenport A.P., O’Reilly G., Molenaar P., Maguire J.J. Kuc R.E., Sharkey A., Bacon C.R., and Ferro A. (1993) Human endothelin receptors characterized using reverse transcriptase-polymerase chain reaction, in situ hybridization and sub-type selective ligands BQ123 and BQ3020:Evidence for expression of ETB receptors in human vascular smooth muscle. J. Cardiovasc. Pharmacol. 22(S8), 22–25.
Molenaar P., O’ Reilly G., Sharkey A., Kuc R.E., Harding D.P., Plumpton P., Gresham G.A., and Davenport A.P. (1993) Characterization and localization of endothelin receptor sub-types in the human atrio-ventricular conducting system and myocardium. Circ. Res. 72, 526–538.
Telemaque-Potts S., Kuc R.E., Yanagisawa M., and Davenport A.P. (2000) Tissue-specific modulation of endothelin receptors in a rat model of hyperten-sion. J. Cardiovasc. Pharmacol. 36(S1), 122–123.
Kuc R.E. and Davenport A.P. (2000) Endothelin-A-receptors in human aorta and pulmonary arteries are down regulated in patients with cardiovascular disease:An adaptive response to increased levels of ET-1?J. Cardiovasc. Pharmacol. 36(S1), 377–379.
Keen M. (ed.) (1999) Receptor Binding Techniques. Humana Press Totowa, NJ.
Hulme E. (1992) Receptor-Ligand Interactions. IRL Oxford, UK.
Kenakin T. (1993) Pharmacologic Analysis of Drug-Receptor Interactions. Raven Press New York, USA.
Davenport A.P. and Russell F.D. (2001) Endothelin converting enzymes and endothelin receptor localisation in human tissues, in Handbook of Experimen-tal Pharmacology, vol. 152 (Warner T.D. ed.), Springer-Verlag Berlin, Ger-many, pp. 209–237.
Davenport A.P. (1997) Distribution of endothelin receptors, in Endothelins in Biology and Medicine (Miller R., Pelton J.T., and Huggins J., eds.), CRC Press Inc Florida. pp. 45–68.
Davenport A.P., O’ Reilly G., and Kuc R.E. (1995) Endothelin ETA and ETB mRNA and receptors expressed by smooth muscle in the human vasculature: majority of the ETA sub-type. Br. J. Pharmacol. 114, 1110–1116.
Davenport A.P. and Maguire J.J. (1994) Endothelin-induced vasoconstriction is mediated by ETA receptors in man. Trends Pharmacol. Sci. 15, 136–137.
Gray G.A. and Webb D.J. (1996) The endothelin system and its potential as a therapeutic target in cardiovascular disease. Pharmacol. Ther. 72, 109–148.
Douglas S.A. and Ohlstein E.H. (1997) Signal transduction mechanisms mediating the vascular actions of endothelin. J. Vasc. Res. 34, 152–64.
Henry P.J. and Goldie R.G. (2001) Endothelin receptors, in Handbook of Experi-mental Pharmacology, vol. 152 (Warner T.D., ed), Springer-Verlag Berlin, Germany, pp. 69–114.
Stanimirovic D.B., Yamamoto T., Uematsu S., and Spatz M. (1994) Endothelin-1 receptor binding and cellular signal transduction in cultured human brain endothelial cells. J. Neurochem. 62, 592–601.
Zhang Y.F., Jeffery S., Burchill S.A., Berry P.A., Kaski J.C. and Carter N.D. (1998) Truncated human endothelin receptor A produced by alternative splicing and its expression in melanoma. Br. J. Cancer 78, 1141–1146.
Shyamala V., Moulthrop T.H., Stratton Thomas J., and Tekamp Olson P. (1994) Two distinct human endothelin B receptors generated by alternative splic-ing from a single gene. Cell Mol. Biol. Res. 40, 285–296.
Elshourbagy N.A., Adamou J.E., Gagnon A.W., Wu H.L., Pullen M., and Nambi P. (1996) Molecular characterization of a novel human endothelin recep-tor splice variant. J. Biol. Chem. 271, 25,300–25,307.
Mizuguchi T., Nishiyama M., Moroi K., Tanaka H., Saito T., Masuda Y., et al. (1997) Analysis of two pharmacologically predicted endothelin B receptor sub-types by using the endothelin B receptor gene knockout mouse. Br. J. Pharmacol. 120, 1427–1430.
Molenaar P., Kuc R.E., and Davenport A.P. (1992) Characterization of two new ETB selective radioligands, [125I]-BQ3020 and [125I]-[Ala1, 3, 11, 15 ]ET-1 in human heart. Br. J. Pharmacol. 107, 637–639.
Davenport A.P., Kuc R.E., Hoskins S.L., Karet F.E., and Fitzgerald F. (1994) [125I]-PD151242:a selective ligand for endothelin ETA receptors in human kidney which localizes to renal vasculature. Brit. J. Pharmacol. 113, 1303–1310.
Peter M.G. and Davenport A.P. (1996) Characterisation of endothelin receptor selective agonist BQ3020 and antagonists BQ123, FR139317, BQ788, 50235, Ro462005 and bosentan in the heart. Brit. J. Pharmacol. 117, 455–462.
Russell F.D. and Davenport A.P. (1996) Characterisation of the binding of endothelin ETB selective ligands in human and rat heart. Brit. J. Pharmacol. 119, 631–636.
Flynn M.A., Haleen S.J., Welch K.M., Cheng X.M., and Reynolds E.E. (1998) Endothelin B receptors on human endothelial and smooth-muscle cells show equivalent binding pharmacology. J. Cardiovasc. Pharmacol. 32, 106–116.
Lecoin L., Sakurai T., Ngo M.T., Abe Y., Yanagisawa M., and Le-Douarin N.M. (1998) Cloning and characterization of a novel endothelin receptor subtype in the avian class. Proc. Natl. Acad. Sci. 95, 3024–3029.
Karne S., Jayawickreme C.K., and Lerner M.R. (1993) Cloning and character-ization of an endothelin-3 specific receptor (ETC receptor) from Xenopus laevis dermal melanophores. J. Biol. Chem. 268, 19126–19133.
Davenport A.P. and Morton A.J. (1991) Binding sites for 125I-125I ET-1, ET-2, ET-3 and vasoactive intestinal contractor are present in adult rat brain and neurone-enriched primary cultures of embryonic brain cells. Brain Res. 554, 278–285.
Bacon C.R.and Davenport A.P. (1996) Endothelin receptors in human coronary artery and aorta. Brit. J. Pharmacol. 117, 986–992.
Maguire J.J., Kuc R.E., Rous B.A., and Davenport A.P. (1996) Failure of BQ123, a more potent antagonist of sarafotoxin S6b than of endothelin-1, to dis-tinguish between these agonists in binding experiments. Brit. J. Pharmacol. 118, 355–342.
Davenport A.P., Kuc R.E., Fitzgerald F., Maguire J.J., Berryman K., and Doherty A.M. (1994) [125I]-PD15242, a selective radioligand for human ETA receptors. Br. J. Pharmacol. 111, 4–6.
Davenport A.P., Kuc R.E., Ashby M.J., Patt W.C., and Doherty A.M. (1998) Characterisation of [125I ]-PD164333, an ETA-selective nonpeptide radiolabeled antagonist, in normal and diseased human tissues. Br. J. Pharmacol. 123, 223–230.
Ihara M., Yamanaka R., Ohwaki K., Ozaki S., Fukami T., Ishikawa K., et al. (1995) [3H]-BQ-123, a highly specific and reversible radioligand for the endothelin ETA receptor subtype. Eur. J. Pharmacol. 274, 1–6.
Watakabe T., Urade Y., Takai M., Umemura I., and Okada T. (1992) A reversible radioligand specific for the ETB receptor, [125I]-]Tyr13-Suc-[Glu9, Ala11, 15 ]-endothelin-1(8–21), [125I]-IRL1620. Biochem. Biophys. Res. Commun. 185, 867–873.
Ihara M., Noguchi K., Saeki T., Fukuroda T., Tsuchida S., Kimura S., et al. (1992) Biological profiles of highly potent novel endothelin antagonists selective for the ET(A)receptor. Life Sci. 50, 247–255.
Aramori I., Nirei H., Shoubo M., Sogabe K., Nakamura K., Kojo H., et al. (1993) Subtype selectivity of a novel endothelin antagonist, FR139317, for the two endothelin receptors in transfected Chinese hamster ovary cells. Mol. Pharmacol. 43, 127–131.
William D.L., Jr., Jones K.L., Pettibone D.J., Lis E.V., and Clineschmidt B. V. (1991) Sarafotoxin S6c, an agonist which distinguishes between endothelin receptor subtypes. Biochem. Biophys. Res Commun. 175, 556–561.
Ishikawa K., Ihara M., Noguchi K., Mase T., Mino N., Saeki T., et al. (1994) Biochemical and pharmacological profile of a potent and selective endothelin B-receptor antagonist, BQ-788. Proc. Natl. Acad. Sci. USA 91, 4892–4896.
Battistini B. and Dussault P. (1998) Blocking of the endothelin system:the development of receptor antagonists. Pulm. Pharmacol. Ther. 11, 97–112.
Peter M.G. and Davenport A.P. (1995) Selectivity of [125I]-PD151242 for the human, rat and porcine endothelin ETA receptors in the heart. Brit. J. Pharmacol. 114, 297–302.
Munson P.J. and Rodbard D. (1980) Ligand:a versatile computerized approach for characterization of ligand-binding systems. Anal. Biochem. 107, 220–239.
McPherson G.A. (1985) Analysis of radioligand binding experiments. A collection of computer programs for the IBM PC. J. Pharmacol. Meth. 14, 213–228.
Davenport A.P. and Hall M.D. (1988) Comparison between brain paste and polymer standards for quantitative receptor autoradiography. J. Neurosci. Meth. 25, 75–82.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Humana Press Inc.
About this protocol
Cite this protocol
Davenport, A.P., Kuc, R.E. (2002). Radioligand binding assays and quantitative autoradiography of endothelin receptors. In: Maguire, J.J., Davenport, A.P. (eds) Peptide Research Protocols. Methods in Molecular Biology™, vol 206. Springer, Totowa, NJ. https://doi.org/10.1385/1-59259-289-9:045
Download citation
DOI: https://doi.org/10.1385/1-59259-289-9:045
Publisher Name: Springer, Totowa, NJ
Print ISBN: 978-0-89603-993-3
Online ISBN: 978-1-59259-289-0
eBook Packages: Springer Protocols